Items where Author is "Bustanji, Y."
![]() | Up a level |
(2026) Global burden of metabolic dysfunction-associated steatotic liver disease, 1990-2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Gastroenterology & Hepatology. pp. 463-494.
(2025) Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Respiratory Medicine. pp. 425-446. ISSN 2213-2600
(2025) Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health. e203-e227. ISSN 24682667 (ISSN)
(2025) Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health. e189-e202. ISSN 24682667 (ISSN)
(2025) Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. pp. 36-51. ISSN 14733099 (ISSN)
(2025) Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Global Health. E1378-E1395. ISSN 2214-109X
(2025) The global, regional, and national burden attributable to low bone mineral density, 1990-2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021. Lancet Rheumatology. E873-E894. ISSN 2665-9913
(2024) Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020. Eye. pp. 2036-2046. ISSN 0950-222X
(2024) National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050. The Lancet. pp. 2278-2298. ISSN 01406736 (ISSN)


